Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Brown Clinic
mi
from
Watertown, SD
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Brown Clinic
mi
from
Watertown, SD
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
ClinSearch, LLC
mi
from
Chattanooga, TN
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Radiant Research Dallas
mi
from
Dallas, TX
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Radiant Research Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Breco Research Inc.
mi
from
Houston, TX
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Breco Research Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Diabetes Center of the Southwest
mi
from
Midland, TX
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Diabetes Center of the Southwest
mi
from
Midland, TX
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Diabetes & Glandular Disease Research Associates, P.A.
mi
from
San Antonio, TX
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Diabetes & Glandular Disease Research Associates, P.A.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Radiant Research - San Antonio
mi
from
San Antonio, TX
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Radiant Research - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Salt Lake Women's Center, P.C.
mi
from
Sandy, UT
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Salt Lake Women's Center, P.C.
mi
from
Sandy, UT
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Fletcher Allan Health Center, UHC Campus 1
mi
from
Burlington, VT
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Fletcher Allan Health Center, UHC Campus 1
mi
from
Burlington, VT
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Center for Arthritis and Diabetes
mi
from
Newport News, VA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Center for Arthritis and Diabetes
mi
from
Newport News, VA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
National Clinical Research, Inc.
mi
from
Richmond, VA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
National Clinical Research, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'MCV Physicians Program for Osteoporosis
mi
from
Richmond, VA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'MCV Physicians Program for Osteoporosis
mi
from
Richmond, VA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Osteoporosis Research Group
mi
from
Seattle, WA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Osteoporosis Research Group
mi
from
Seattle, WA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'University of Wisconsin Medical Foundation
mi
from
Madison, WI
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'University of Wisconsin Medical Foundation
mi
from
Madison, WI
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'IDIM
mi
from
Buenos Aires,
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'IDIM
mi
from
Buenos Aires,
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'Boling Clinical Trials
mi
from
Rancho Cucamonga, CA
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'Boling Clinical Trials
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'Radiant Research - Lake Worth
mi
from
Lake Worth, FL
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'Radiant Research - Lake Worth
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
Odyssey Research/Bone Density of North Idaho
mi
from
Coeur d'Alene, ID
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
Odyssey Research/Bone Density of North Idaho
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
University of Chicago
mi
from
Chicago, IL
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'University Hospital & Outpatient Center
mi
from
Indianapolis, IN
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'University Hospital & Outpatient Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'Bethesda Health Research Center
mi
from
Bethesda, MD
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'Bethesda Health Research Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
Michigan Bone and Mineral Clinic, PC
mi
from
Detroit, MI
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
Michigan Bone and Mineral Clinic, PC
mi
from
Detroit, MI
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
Odyssey Research
mi
from
North Platte, NE
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
Odyssey Research
mi
from
North Platte, NE
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
Creighton University School of Medicine
mi
from
Omaha, NE
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
Creighton University School of Medicine
mi
from
Omaha, NE
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
New Mexico Clinical Research & Osteoporosis Center
mi
from
Albuquerque, NM
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
New Mexico Clinical Research & Osteoporosis Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'Odyssey Research Services
mi
from
Bismarck, ND
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'Odyssey Research Services
mi
from
Bismarck, ND
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
Michael J. Lillestol
mi
from
Fargo, ND
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
Michael J. Lillestol
mi
from
Fargo, ND
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'Odyssey Research Services
mi
from
Minot, ND
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'Odyssey Research Services
mi
from
Minot, ND
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'Radiant Research
mi
from
Wyomissing, PA
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'Radiant Research
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
Odyssey Research/Avera United Clinic
mi
from
Aberdeen, SD
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
Odyssey Research/Avera United Clinic
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
Brown Clinic
mi
from
Watertown, SD
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
Brown Clinic
mi
from
Watertown, SD
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'Diabetes Center of the Southwest
mi
from
Midland, TX
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'Diabetes Center of the Southwest
mi
from
Midland, TX
Click here to add this to my saved trials
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated:  11/11/2015
'IDIM
mi
from
Buenos Aires,
Calcium Supplementation in Postmenopausal Women
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Status: Enrolling
Updated: 11/11/2015
'IDIM
mi
from
Buenos Aires,
Click here to add this to my saved trials
DXA Precision and Accuracy Comparison Study
DXA Precision and Accuracy Comparison Study
Status: Enrolling
Updated:  11/15/2015
Colorado Center for Bone Research
mi
from
Lakewood, CO
DXA Precision and Accuracy Comparison Study
DXA Precision and Accuracy Comparison Study
Status: Enrolling
Updated: 11/15/2015
Colorado Center for Bone Research
mi
from
Lakewood, CO
Click here to add this to my saved trials
Evaluation of VLER-Indiana Health Information Exchange Demonstration Project
Evaluation of VLER_Indiana Health Information Exchange Demonstration Project
Status: Enrolling
Updated:  12/22/2015
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Evaluation of VLER-Indiana Health Information Exchange Demonstration Project
Evaluation of VLER_Indiana Health Information Exchange Demonstration Project
Status: Enrolling
Updated: 12/22/2015
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm
Status: Enrolling
Updated:  12/22/2015
Institute for Human Performance/Upstate Medical University
mi
from
Syracuse, NY
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm
Status: Enrolling
Updated: 12/22/2015
Institute for Human Performance/Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Pilot Study of Fosamax in Spinal Cord Injury
Double Blind Placebo Controlled Trial to Evaluate Preservation of Bone Mineral Density of the Hip and Distal Femur by Biphosphate Therapy (Fosamax) Following Spinal Cord Injury
Status: Enrolling
Updated:  12/25/2015
University of Rochester
mi
from
Rochester, NY
Pilot Study of Fosamax in Spinal Cord Injury
Double Blind Placebo Controlled Trial to Evaluate Preservation of Bone Mineral Density of the Hip and Distal Femur by Biphosphate Therapy (Fosamax) Following Spinal Cord Injury
Status: Enrolling
Updated: 12/25/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Pilot Study of Fosamax in Spinal Cord Injury
Double Blind Placebo Controlled Trial to Evaluate Preservation of Bone Mineral Density of the Hip and Distal Femur by Biphosphate Therapy (Fosamax) Following Spinal Cord Injury
Status: Enrolling
Updated:  12/25/2015
University of Rochester Physical Medicine and Rehabilitation
mi
from
Rochester, NY
Pilot Study of Fosamax in Spinal Cord Injury
Double Blind Placebo Controlled Trial to Evaluate Preservation of Bone Mineral Density of the Hip and Distal Femur by Biphosphate Therapy (Fosamax) Following Spinal Cord Injury
Status: Enrolling
Updated: 12/25/2015
University of Rochester Physical Medicine and Rehabilitation
mi
from
Rochester, NY
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Little Rock, AR
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Irvine, CA
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Rancho Mirage, CA
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Leesburg, FL
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Leesburg, FL
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Gainesville, GA
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Coeur D'Alene, ID
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Bethesda, MD
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
St Louis, MO
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Billings, MT
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Omaha, NE
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Albuquerque, NM
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials